KRAS and colorectal carcinoma: We then considered whether this also occurs in malignant cells, and for this reason we employed a panel of isogenic CRC cell lines where mutated KRAS is either KI (+/+ and D13/+, SW48 and Lim1215) or KO (D13/− and +/−, HCT-116 and DLD1).